Literature DB >> 1654144

In vivo expression of IL-1 beta and IL-6 genes during viral infections in human.

O Devergne1, M Peuchmaur, M Humbert, E Navratil, M B Leger-Ravet, M C Crevon, M A Petit, P Galanaud, D Emilie.   

Abstract

Macrophage infiltration is a constant feature of human virus-infected tissues. However, the in situ functional status of these cells remains undetermined. In order to document an activation of macrophages in virus-infected tissues, the expression of IL-1 beta and IL-6 genes was analyzed using in situ hybridization. Several tissues were studied, as well as infections induced by different viruses: lymph nodes infected by HIV-1 (9 cases) or EBV (one case), lungs infected by CMV (5 cases) or adenovirus (1 case), livers infected by HBV, either chronically (2 cases) or acutely (7 cases presenting a fulminant hepatitis). With the exception of fulminant HBV hepatitis, IL-1 beta and IL-6 genes were expressed in all cases. IL-1 beta and IL-6 genes were usually coordinately regulated, as cells containing IL-1 beta or IL-6 mRNA were present in identical amounts and displayed a similar distribution. Analysis of the location and the morphology of monokine gene-expressing cells indicated that both small macrophages and endothelial cells expressed IL-1 beta and IL-6 genes. However, neither tingible body macrophages present in lymph node follicles nor Kupffer cells expressed these genes at a detectable level. Infected cells themselves were also negative for monokine gene expression. These findings indicate that expression of IL-1 beta and IL-6 genes by reactive cells may play a role in viral spreading limitation as well as virus-induced tissue damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654144

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  9 in total

1.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

2.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 3.  Cytokines and cytokine measurements in a clinical laboratory.

Authors:  T L Whiteside
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

4.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

Authors:  A D Wagner; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.

Authors:  Debjani Guha; Cynthia R Klamar; Todd Reinhart; Velpandi Ayyavoo
Journal:  J Interferon Cytokine Res       Date:  2014-12-23       Impact factor: 2.607

Review 6.  Immunomodulatory roles of human herpesvirus-encoded microRNA in host-virus interaction.

Authors:  Afsar R Naqvi
Journal:  Rev Med Virol       Date:  2019-08-20       Impact factor: 6.989

7.  Association of T cell and macrophage dysfunction with surface gp 120-immunoglobulin-complement complexes in HIV-infected patients.

Authors:  V Daniel; C Süsal; R Weimer; R Zimmermann; A Huth-Kühne; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain.

Authors:  T Cartmell; T Southgate; G S Rees; M G Castro; P R Lowenstein; G N Luheshi
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 9.  Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?

Authors:  Solène Grayo
Journal:  Viruses       Date:  2021-04-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.